When combining IκBα levels with MS status as a biomarker for predicting curcumin sensitivity, the combination could correctly distinguish the curcumin-sensitive CRC cell lines from curcumin-resistant CRC cell lines with an approximately 72% predictive power. The gene discussed is NFKBIA; the disease is colorectal carcinoma.